PAR
Click for more information
11.1% 30.0¢ paradigm biopharmaceuticals limited..

Ann: PARs European Patent Granted for Bone Marrow Edema Lesions
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    16/01/18
    08:51
    Post #: 30328889
    • Release Date: 16/01/18 08:31
    • Summary: PARs European Patent Granted for Bone Marrow Edema Lesions
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
    Likes Created with Sketch. 1  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Things finally 'looking different' for up-and-down Hot Stock tip Stockland
right-arrow Created with Sketch.
RMS High-grade Gold and Copper findings drive excitement at Red Mountain’s Flicka Lake
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢ 		Change
0.030(11.1%) 		Mkt cap ! $82.30M
Open High Low Value Volume
27.5¢ 30.0¢ 27.5¢ $447.9K 1.554M

Buyers (Bids)

No. Vol. Price($)
4 257067 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 139039 6
View Market Depth
Last trade - 12.59pm 22/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.